FindTrial
Sign In

Desmopressin Acetate

DRUG5 trials

Sponsors

Centers for Disease Control and Prevention, Ferring Pharmaceuticals, Cairo University, National Institute of Neurological Disorders and Stroke (NINDS), Mansoura University

Conditions

Blood Coagulation DisordersBlood Platelet DisordersCushing's DiseaseHematologic DiseaseMenorrhagiaNocturiaNocturnal Polyurea in Patients With BPHPituitary Adenoma

Phase 3

Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia
CompletedNCT00477490
Ferring PharmaceuticalsNocturia
Start: 2007-05-31End: 2008-02-29Updated: 2015-11-02

Phase 4

Posterior Tibial Nerve Stimulation Vs Desmopressin In Children With Primary Monosymptomatic Nocturnal Enuresis
NCT04545931
Cairo UniversityPrimary Monosymptomatic Nocturnal Enuresis
Start: 2020-03-15End: 2020-12-15Target: 80Updated: 2020-09-11
Adding Desmopressin to Tamsulosin for Treatment of BPH
NCT05945420
Mansoura UniversityNocturnal Polyurea in Patients With BPH
Start: 2023-07-20End: 2024-02-10Target: 160Updated: 2023-07-14

Unknown Phase

Treatment and Management of Women With Bleeding Disorders
CompletedNCT00111215
Centers for Disease Control and PreventionBlood Coagulation Disorders, Blood Platelet Disorders, Hematologic Disease +2
Start: 2001-01-31End: 2006-09-30Target: 100Updated: 2007-03-13
DDAVP for Pituitary Adenoma
RecruitingNCT04569591
National Institute of Neurological Disorders and Stroke (NINDS)Cushing's Disease, Pituitary Adenoma
Start: 2026-03-09End: 2028-02-26Target: 22Updated: 2026-04-01

Related Papers

Increases in duration of first uninterrupted sleep period are associated with improvements in PSQI-measured sleep quality.
2014-06-1329 citations